|
Composition |
|
Yohimbine Hydrochloride 10 mg/ml. |
| |
|
|
|
Action |
|
Yohimbine
is an indolalkylamine alkaloid that acts primarily by blocking central alpha-2
adrenoreceptors that are stimulated by Xylazine. It completely blocks and
antagonizes central nervous system depression or sedation and the bradycardia
and respiratory depression caused by Xylazine. |
| |
|
|
|
Indications |
|
For the reversal of Xylazine-based sedation and anaesthesia in Deer and Dogs. |
| |
|
|
|
Precautions |
|
It is contraindicated in
Cardiovascular, Renal or Hepatic disorders. |
| |
|
|
|
Dosage and Administration |
|
By
Intravenous Injection only 0.25 ml. per 10 kg. Body. |
| |
|
|
|
Withholding Period |
|
Do
not administer later than 28 days before slaughter for Human Consumption. |
| |
|
|
|
Presentation |
|
Vial
- 50 ml (Multidose). |
| |
|
|
|
Storage |
|
Store below
300 C. Protect from light. |
